Guidelines for the Treatment of Hepatitis C Virus Infection in Injection Drug Users: Status Quo in the European Union Countries
Open Access
- 15 April 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (s5) , S373-S378
- https://doi.org/10.1086/427456
Abstract
Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelinesKeywords
This publication has 21 references indexed in Scilit:
- National Institutes of Health Consensus Development Conference Statement Management of Hepatitis C: 2002 June 10-12, 2002HIV Research & Clinical Practice, 2003
- Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groupsHepatology, 2003
- Prevention and treatment of hepatitis C in injection drug usersHepatology, 2002
- Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2bClinical Therapeutics, 2002
- Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?New England Journal of Medicine, 2001
- Treatment of Hepatitis C Infection in Injection Drug UsersHepatology, 2001
- Clinical guidelines on the management of hepatitis CGut, 2001
- Managing chronic hepatitis C acquired through intravenous drug useQJM: An International Journal of Medicine, 2001
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998